ArticlePediatric research2026
Surfactant proteins A and D nucleotide variants: association with retinal vascular disease.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundRetinopathy of prematurity (ROP) is associated with systemic inflammation. Surfactant proteins A and D (SP-A and SP-D) play an immunomodulatory role. We previously reported the impact of SP-A on retinal angiogenesis. This study investigates SP-A and SP-D single-nucleotide polymorphisms (SNPs) with risk of ROP.
methodsSubjects were infants with gestational age (GA) of <32 weeks and/or birth weight <1500 grams. DNA from blood was used to genotype the SNPs. Statistical analysis used logistic regression for the association of ROP with genetic and clinical factors, including bronchopulmonary dysplasia (BPD), GA, and oxygen exposure.
resultsA total of 59 infants were enrolled. In the whole cohort, the SFTPA1 SNP rs1059057 'G' allele was associated with increasing odds of ROP when controlling for GA and oxygen. In both the whole cohort and in BPD, the SFTPA2 SNP rs1965707 'T' allele was associated with increasing odds of ROP risk when controlling for GA and oxygen. Furthermore, there was an interaction effect where the protective effect of GA in the presence of the wildtype (C/C) was diminished in the presence of the 'T' allele.
conclusionsThe study identifies novel associations between surfactant protein gene SNPs and ROP risk that may impact protein structure, function in the retinal vasculature. IMPACT: Retinopathy of Prematurity (ROP) stems from disrupted angiogenesis. Surfactant protein A (SP-A) impacts retinal vascular disease, but associations between genetic polymorphisms of surfactant proteins (SPs) and ROP are unknown. We report novel surfactant protein polymorphisms and ROP. The risk of ROP modeled by controlling for gestational age (GA) and oxygen suggests novel direct effects on endothelial function and angiogenesis. The resultant amino acid substitutions were mapped to predict translational protein modifications. As SNPs alter amino acid structure, protein folding, and functionality, our results provide critical mechanistic clues for vascular diseases of prematurity. Mapping of genetic signatures enables earlier detection of ROP.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.